| Company Name: |
Shanghai Yifei Biotechnology Co. , Ltd.
|
| Tel: |
021-65675885 18964387627 |
| Email: |
customer_service@efebio.com |
| Products Intro: |
Product Name:BMS-929075 CAS:1217338-97-0 Purity:98% Package:1mg;5mg;10mg
|
| Company Name: |
RD International Technology Co., Limited
|
| Tel: |
18024082417 |
| Email: |
market@ubiochem.com |
| Products Intro: |
Product Name:BMS-929075 CAS:1217338-97-0 Purity:5mg;10mg;50mg;100mg;250mg;500mg;1g Package:5mg;10mg;50mg;100mg;250mg;500mg;1g
|
| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
15002134094 |
| Email: |
marketing@targetmol.cn |
| Products Intro: |
Product Name:BMS-929075 CAS:1217338-97-0 Purity:99.94% Package:1removed
|
BMS-929075 manufacturers
- BMS-929075
-
- $190.00 / 1mg
-
2026-04-13
- CAS:1217338-97-0
- Min. Order:
- Purity: 99.94%
- Supply Ability: 10g
- BMS-929075
-
- $6.05 / 1ASSAYS
-
2024-10-22
- CAS:1217338-97-0
- Min. Order: 200g
- Purity: 95.0%-99.0%
- Supply Ability: 100kg
|
| | BMS-929075 Basic information |
| Product Name: | BMS-929075 | | Synonyms: | BMS-929075;3-Benzofurancarboxamide, 4-fluoro-2-(4-fluorophenyl)-N-methyl-5-[2-methyl-5-[[[1-(2-pyrimidinyl)cyclopropyl]amino]carbonyl]phenyl]-;4-Fluoro-2-(4-fluorophenyl)-n-methyl-5-(2-methyl-5-((1-(pyrimidin-2-yl)cyclopropyl)carbamoyl)phenyl)benzofuran-3-carboxamide;BMS-929075, 10 mM in DMSO | | CAS: | 1217338-97-0 | | MF: | C31H24F2N4O3 | | MW: | 538.54 | | EINECS: | | | Product Categories: | | | Mol File: | 1217338-97-0.mol |  |
| | BMS-929075 Chemical Properties |
| Boiling point | 725.5±60.0 °C(Predicted) | | density | 1.41±0.1 g/cm3(Predicted) | | pka | 12.76±0.20(Predicted) |
| | BMS-929075 Usage And Synthesis |
| Uses | BMS-929075 is a potent and orally active HCV NS5B replicase palm site allosteric inhibitor. BMS-929075 shows high oral bioavailability. BMS-929075 shows cytotoxicity[1]. | | in vivo | BMS-929075 (compound 37) (2 mg/kg for i.v.; 6 mg/kg for p.o.) shows good pharmacokinetic parameters with oral bioavailability of 48% in rats[1]. Pharmacokinetic Parameters of BMS-929075 in Male Sprague-Dawley rats[1].
| IV | | | PO | | | | | | | | species | Cl (mL/min/kg) | IV t1/2(hr) | Vss(L/kg) | Cmax(μM) | Tmax(hr) | AUC (μM h) | C6 liver (μM) | C24 liver (μM) | C24 liver/plasma (μM) | F% (mL/min/kg) | | rat | 1.7 | 4.7 | 0.7 | 7.5 | 4 | 54.5 | 15.1 | 1.12 | 1.6 | 48 |
Rats, 2 mg/kg i.v.; 6 mg/kg p.o. [1].
| | References | [1] Yeung KS, et al. Discovery of a Hepatitis C Virus NS5B Replicase Palm Site Allosteric Inhibitor (BMS-929075) Advanced to Phase 1 Clinical Studies. J Med Chem. 2017 May 25;60(10):4369-4385. DOI:10.1021/acs.jmedchem.7b00328 |
| | BMS-929075 Preparation Products And Raw materials |
|